ANI PHARMACEUTICALS, INC Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
ANI PHARMACEUTICALS, INC (ANIP) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of $0.00 per share for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-23.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2016-02-23
- ANI PHARMACEUTICALS, INC income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- ANI PHARMACEUTICALS, INC income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2013-09-30 was $0.02.
- ANI PHARMACEUTICALS, INC income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2015 was $0.00.
- ANI PHARMACEUTICALS, INC income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- ANI PHARMACEUTICALS, INC income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2013 was $0.04.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month |
|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-02-23 | ||
| 2014-12-31 | $0.00 10-K · filed 2016-02-23 | ||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | |
| 2013-12-31 | $0.04 10-K · filed 2016-02-23 | ||
| 2013-09-30 | $0.02 10-Q · filed 2014-11-10 | $0.04 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |